Comparing Sevoflurane With Propofol Sedation in ESRF Patients

• Status: Not yet recruiting
• Trial end date: 2022-04-30
• Target enrollment: 0
• Participant gender: All

Summary

End-stage renal failure (ESRF) cohorts undergo brachiocephalic fistula(BCF) transposition with supraclavicular block. However, this is inadequate because the incision may extend to the axillary region which requires intercostobrachial (T2) dermatome blockage. Sedation is commonly indicated to allay anxiety whilst allowing intraprocedural lignocaine infiltration. It is challenging to administer safe sedation to ESRF patients due to multiple comorbidities, polypharmacy, altered pharmacokinetic drug handling. Intraoperative hypotension can be common and evident from the residual effect of antihypertensive and intravascular hypovolemia from regular hemodialysis. Midazolam is metabolized to an active metabolite which can accumulate causes apnea and delayed recovery. TCI propofol needs higher induction doses to achieve hypnosis causes exaggerated hypotension which may jeopardize organ perfusion. The investigators are exploring the potential benefit of sevoflurane sedation which are independent of renal clearance, rapid onset and offset, and ischemic preconditioning property in ESRF cohorts.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Malaya
• Treatments: Sevoflurane

Criteria

Inclusion Criteria:

• Patient with end stage renal failure, dialysis dependent undergoing transposition of brachiocephalic fistula repair

• American Society of Anesthesiology Physical Status Classification System (ASA) II or III

Exclusion Criteria:

• Patient refusal

• History or family history of malignant hyperthermia

• Known allergy to propofol or local anaesthetic agent

• Patients who have taken neuroleptics, benzodiazepine over 2 weeks within 1 month

• Chronic use of alcohols/ opioid

• Active lungs disease (eg. acute exacerbation of chronic obstructive pulmonary disease)

• Active and significant cardiac disease (eg. decompensated congestive cardiac failure, recent myocardial infarction)

• End-stage heart failure with left ventricular ejection fraction < 30%

• Recent (< 3 months) cerebrovascular accident